In this study, serum resistin, TNF-α, and leptin levels were dramatically reduced by SRPE-3-Cr(III) treatment, indicating SRPE-3-Cr(III) alleviated insulin resistance by inhibiting the secretion of serum resistin, leptin, and TNF-α from adipocytes. Here, LEP is linked to Insulin resistance.